Page last updated: 2024-08-17

thymidine and ct-32228

thymidine has been researched along with ct-32228 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatt, R; Bonham, L; Carew, H; Hackman, RC; Hockenbery, DM; Hollenback, D; Laugen, C; Pagel, JM; Press, OW; Singer, JW	1

Other Studies

1 other study(ies) available for thymidine and ct-32228

Article	Year
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13 Topics: Acyltransferases; Alanine Transaminase; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartate Aminotransferases; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydrocarbons, Halogenated; Injections, Intraperitoneal; Lymphoma, Non-Hodgkin; Mice; Mice, Nude; Mice, SCID; Rituximab; Specific Pathogen-Free Organisms; Survival Analysis; Thymidine; Time Factors; Treatment Outcome; Triazines; Tritium; Xenograft Model Antitumor Assays	2005

Article

Year

Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13

Topics: Acyltransferases; Alanine Transaminase; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartate Aminotransferases; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydrocarbons, Halogenated; Injections, Intraperitoneal; Lymphoma, Non-Hodgkin; Mice; Mice, Nude; Mice, SCID; Rituximab; Specific Pathogen-Free Organisms; Survival Analysis; Thymidine; Time Factors; Treatment Outcome; Triazines; Tritium; Xenograft Model Antitumor Assays

2005